id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-V-5190-0003,FDA,FDA-2023-V-5190,Variance Approval Letter from FDA CDRH to ACT Entertainment,Other,Approval for Variance (VRA),2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T13:52:27Z,,0,0,090000648635a687
FDA-2023-V-5190-0002,FDA,FDA-2023-V-5190,Acknowledgment Letter from FDA DMS to ACT Entertainment,Other,Acknowledgement Letter/Receipt,2023-11-24T05:00:00Z,2023,11,2023-11-24T05:00:00Z,,2023-11-24T20:46:14Z,,0,0,09000064862ac594
FDA-2023-V-5190-0001,FDA,FDA-2023-V-5190,Variance Application from ACT Entertainment,Other,Application for Variance (VAR),2023-11-24T05:00:00Z,2023,11,2023-11-24T05:00:00Z,,2023-11-24T20:44:10Z,,0,0,09000064862ac590